SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns fiscal Q4 earnings and forward guidance are the dominant focus, with traders pointing to AI-driven demand and tight DRAM, NAND and HBM supply as support for pricing and growth. Optimism about a strong report is tempered by worries that high expectations are already priced in and that the memory upcycle may not last, raising the prospect of a sell-the-news reaction.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

TTDs prolonged selloff to multi-year lows is being tied to slowing growth, a weak advertising outlook, and competitive pressure from Amazon and AI-driven ad platforms. Traders are also debating an Apple/Safari ad-serving issue, while frustration with management and its incentive package contrasts with some bullish arguments based on cash generation and the possibility of a rebound.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

A GAO report identifying gaps in federal drug-scheduling procedures has prompted the cannabis rescheduling hearing to pause while the administrative judge considers whether to add the report to the record. Traders are divided between viewing this as a temporary procedural delay and fearing it could prolong or complicate the path to Schedule III; many see the selloff as an overreaction and are buying the dip.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances shares surged after the company raised its full-year revenue outlook, citing stronger demand for Amtagvi and Proleukin. Traders largely welcomed the sales growth and discussed possible short covering, while others cautioned about the sharp run-up and potential dilution; upcoming cancer-treatment data also featured in the bullish outlook.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Ryan Cohens reported purchases of GameStop shares are driving attention, with bullish traders treating them as a confidence signal and speculating about a short squeeze or warrant-related move. Others argue insider buying alone is not enough without substantive company news, and point to fading momentum and resistance around recent levels.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

The FHFAs move to include VantageScore alongside FICO in Fannie Mae and Freddie Mac mortgage pricing has raised concerns that competition could erode FICOs long-standing mortgage-scoring advantage and pricing power, driving a sharp selloff. Traders are split between viewing the decline as a fundamental repricing of the business and looking for an oversold relief bounce.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Discussion is focused on a pause in the administrative judges cannabis-rescheduling process, with the judge seeking a DEA response on whether to reopen the hearing record before issuing a recommendation. Traders are frustrated by the delay, though some view it as temporary and remain optimistic about eventual Schedule III rescheduling.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths planned Nasdaq listing through its Armada SPAC merger is driving attention, with traders focused on the shareholder vote, the proposed XRP treasury, and filings advancing the deal. Excitement over a sharp, volatile move and the warrants is balanced by uncertainty about merger completion and redemptions.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solars sharp rebound from a 52-week low on elevated volume has renewed attention, with traders speculating that heavy short interest could amplify the move. Some bulls point to improving margin prospects as U.S. manufacturing ramps, while skeptics remain focused on debt, recent losses and weak solar-sector conditions.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on Capricors planned presentation of 24-month HOPE-3 open-label extension data for deramiocel at the World Muscle Society congress, ahead of the FDAs review of the drugs application for Duchenne muscular dystrophy. Bulls expect the added data to strengthen the case for approval, while skeptics question the statistical analysis plan and whether open-label results will address the FDAs concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


jameslabrie

james labrie